Patents Assigned to CHONGQING TIANBAIKANG BIOTECHNOLOGY CO., LTD.
  • Publication number: 20190256549
    Abstract: Provided are panaxdiol-type ginsenoside derivatives having structures as shown in formula I or formula II. Also provided are the uses thereof in the preparation of drugs for preventing and treating atherosclerosis. The panaxdiol-type ginsenoside derivatives have low cytotoxicities, can significantly reduce the percentages of the areas of atherosclerotic plaques in apoE?/?mice, can also effectively reduce the levels of low-density lipoprotein cholesterol and increase the levels of high-density lipoprotein cholesterol in serums of mice, and can significantly reduce the local TNF-? levels in the arteries of apoE?/?mice and have good anti-inflammatory effects; at a dose of 30 ?M, the panaxdiol-type ginsenoside derivatives can significantly reduce the degrees of the formation of RAW264.7 cell-derived foam cells. In addition, the preparation methods for the panaxdiol-type ginsenoside derivatives are easy to operate and obtain high yields.
    Type: Application
    Filed: September 15, 2017
    Publication date: August 22, 2019
    Applicants: ARMY MEDICAL UNIVERSITY, CHONGQING TIANBAIKANG BIOTECHNOLOGY CO., LTD.
    Inventors: Xiaohui LI, Yi JIA, Yan HUANG